<DOC>
	<DOCNO>NCT03025971</DOCNO>
	<brief_summary>A prospective , multicenter , nonrandomized , single-arm , control target value study , design include less 82 patient least two ( 2 ) clinical center China .</brief_summary>
	<brief_title>Safety &amp; Efficacy J-Valve Ausper System Patients With Severe Aortic Stenosis and/or Aortic Regurgitation</brief_title>
	<detailed_description>To evaluate safety efficacy J-Valve Ausper system treatment patient severe aortic stenosis and/or aortic regurgitation elevate risk surgery . A prospective , multicenter , nonrandomized , single-arm , control target value study , design include less 82 patient least two ( 2 ) clinical center China .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Aortic Valve Insufficiency</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Heart Valve Diseases</mesh_term>
	<criteria>1 . Signed Informed Consent 2 . Age ≥18years age 3 . Presents symptomatic aortic stenosis and/or aortic regurgitation , well NYHA rating NYHA ≥ II 4 . Has undergone diagnosis least one interventional cardiologist two cardiac surgeon : patient contraindicate traditional open heart valve replacement surgery ( define 30 day postop mortality risk &gt; 50 % , irreversible complication , influential postoperative factor [ severe calcification ascend aorta aortic valve , weak physical condition , chest deformity , severe liver disease , severe lung disease , etc . ] high risk surgery ( LogEuroSCORE≥20 % STS≥8 ) 5 . Has diagnosis least one interventional cardiologist two cardiac surgeon patient may benefit valve implantation 6 . Severe aortic stenosis electrocardiography result follow : mean transvalvular pressure gradient ≥40 mmHg maximal forward aortic blood flow velocity ≥4.0 m/s , aortic valve area &lt; 0.8 cm2 ( AVA index &lt; 0.5 cm2/m2 ) ; and/or severe aortic regurgitation , electrocardiography result show symptomatic moderate regurgitation severe regurgitation 7 . Without severe pulmonary arterial hypertension 8 . The patient willing cooperate followup visit . Anatomical 9 . Aortic annulus &gt; 19mm &lt; 29mm , standardize use cardiac CT measurement ; 10 . Ascending aortic diameter &lt; 50mm sinotubular junction . 1 . Patients infection sign infection 2 . Previous history endocarditis patient active endocarditis 3 . Incidence acute myocardial infarction within past 30 day ( Qwave MI , non Qwave MI creatine kinase , increase troponin T ) 4 . Any cardiac mass discover echocardiography , leave ventricular atrial thrombosis 5 . Suffering uncontrollable atrial fibrillation 6 . Hereditary hypertrophic cardiomyopathy 7 . Mitral tricuspid valve insufficiency ( Class Ⅱ regurgitation great ) 8 . Has previously undergone aortic valve implantation ( mechanical valve biological valve frame ) 9 . Is know allergic contrast agent , aspirin , heparin , ticlopidine medication , nitinol porcine product 10 . Is know contraindicated allergic anticoagulant unable use anticoagulant study 11 . Is know one follow condition ( accord evaluation begin screen day procedure ) : Other disease may reduce life expectancy le 12 month ( clinically recurrent metastatic cancer , congestive heart failure , etc . ) Currently drug abuse problem ( alcohol , cocaine , heroin , etc . ) Plans undergo surgery may result noncompliance study protocol may cause confusion data interpretation . 12 . Has experience cerebrovascular accident ( CVA ) within last 6 month 13 . Patients suffer stenosis carotid , internal carotid , vertebral artery ( 70 % ) 14 . White cell count ＜3×109/L , platelet count＜50×109/L 15 . Hemoglobin ＜90 g/L 16 . Severely lowered leave ventricular function , leave ventricular ejection fraction &lt; 20 % 17 . Aortic aneurysm abdomen chest 18 . Hepatic encephalopathy acute active hepatitis 19 . Currently undergoing dialysis baseline creatine level &gt; 2.5 mg/dL ( 221μmoI/L ) 20 . Prone bleeding , history clot disorder refuse blood transfusion 21 . Active ulcer active gastrointestinal ( GI ) bleed 22 . Suffering nervous system diseases severely influence patient ' ability move perform daily activity 23 . Patients severe dementia 24 . Any reason emergent surgery 25 . Taking part clinical trial pharmaceutical medical device 26 . Those pregnant , plan become pregnant , take estrogen estrogenlike drug ( woman suspect pregnant must test negative urine pregnancy test chorionic gonadotropin serum ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Severe Aortic Stenosis and/or severe aortic regurgitation</keyword>
</DOC>